| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 0 | 0 | 0 | 0 | 0 | 374.198 | 391.732 | 380.837 | 546.879 |
| Total Income - EUR | - | 0 | 0 | 0 | 0 | 0 | 374.198 | 392.617 | 380.837 | 546.883 |
| Total Expenses - EUR | - | 73 | 805 | 422 | 2.568 | 4.011 | 255.715 | 288.476 | 253.855 | 421.643 |
| Gross Profit/Loss - EUR | - | -73 | -805 | -422 | -2.568 | -4.011 | 118.482 | 104.141 | 126.983 | 125.240 |
| Net Profit/Loss - EUR | - | -73 | -805 | -422 | -2.568 | -4.011 | 115.114 | 100.411 | 123.745 | 107.811 |
| Employees | - | 1 | 1 | 0 | 0 | 1 | 4 | 5 | 5 | 8 |
Check the financial reports for the company - Vabiscan Drn Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 83 | 791 | 1.697 | 6.463 | 4.743 | 15.380 | 31.716 | 43.944 | 97.857 |
| Current Assets | - | 130 | 238 | 364 | 191 | 395 | 134.787 | 84.134 | 106.405 | 100.329 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 2.199 | 1.563 | 1.822 | 0 |
| Receivables | - | 0 | 189 | 283 | 181 | 197 | 70.325 | 52.605 | 76.650 | 83.382 |
| Cash | - | 130 | 49 | 81 | 9 | 198 | 62.264 | 29.966 | 27.933 | 16.947 |
| Shareholders Funds | - | -28 | -832 | -1.239 | -3.783 | -7.723 | 107.563 | 100.460 | 123.794 | 108.060 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 241 | 1.861 | 3.300 | 10.438 | 12.862 | 42.604 | 15.390 | 26.555 | 90.127 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4941 - 4941" | |||||||||
| CAEN Financial Year |
4941
|
|||||||||
Comments - Vabiscan Drn Srl